Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure

Ketogenic Metabolism Inhibits Histone Deacetylase (HDAC) and Reduces Oxidative Stress After Spinal Cord Injury in Rats

(2017) Xiaomeng Wang et al.   NEUROSCIENCE

Inhibition of Cartilage Acidic Protein 1 Reduces Ultraviolet B Irradiation Induced-Apoptosis through P38 Mitogen-Activated Protein Kinase and Jun Amino-Terminal Kinase Pathways

(2016) Yinghong Ji et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Effects of histone acetylation on superoxide dismutase 1 gene expression in the pathogenesis of senile cataract

(2016) Xianfang Rong et al.   Scientific Reports

Ultraviolet-B induces ERCC6 repression in lens epithelium cells of age-related nuclear cataract through coordinated DNA hypermethylation and histone deacetylation

(2016) Yong Wang et al.   Clinical Epigenetics

Apoptosis Factors of Lens Epithelial Cells Responsible for Cataractogenesis in Vitrectomized Eyes with Silicone Oil Tamponade

(2016) Lili Zhu et al.   MEDICAL SCIENCE MONITOR

Trichostatin A, a histone deacetylase inhibitor, reverses epithelial–mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells

(2015) Xiaoxiong Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma

(2015) Yongxia Zheng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition

(2015) Jagannath Behera et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Are Increased Levels of Systemic Oxidative Stress and Inflammation Associated with Age-Related Cataract?

(2014) Jinjin Zheng Selin et al.   ANTIOXIDANTS & REDOX SIGNALING

Acetylcholine Promotes ROS Detoxification Against Hypoxia/reoxygenation-Induced Oxidative Stress Through FoxO3a/PGC-1a Dependent Superoxide Dismutase

(2014) Lei Sun et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

β-hydroxybutyrate: Much more than a metabolite

(2014) John C. Newman et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide

(2014) Yuval Samuni et al.   FREE RADICAL BIOLOGY AND MEDICINE

Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases

(2013) Frank J. Dekker et al.   DRUG DISCOVERY TODAY

Toxicological and metabolic considerations for histone deacetylase inhibitors

(2013) Joanna Fraczek et al.   Expert Opinion on Drug Metabolism & Toxicology

Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells

(2013) Yunshuai Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Ketone bodies as signaling metabolites

(2013) John C. Newman et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells

(2013) X Chen et al.   Cell Death & Disease

Histone Deacetylation Inhibition in Pulmonary Hypertension

(2012) Lan Zhao et al.   CIRCULATION

Histone deacetylase inhibitors: a patent review (2009 – 2011)

(2012) Vincenzo Carafa et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Histone deacetylase inhibitors preserve function in aging axons

(2012) Selva Baltan   JOURNAL OF NEUROCHEMISTRY

Suppression of Oxidative Stress by  -Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

(2012) T. Shimazu et al.   SCIENCE

Role of Ultraviolet Irradiation and Oxidative Stress in Cataract Formation—Medical Prevention by Nutritional Antioxidants and Metabolic Agonists

(2011) Shambhu D Varma et al.   Eye & Contact Lens-Science and Clinical Practice

Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells

(2010) Jingyi Li et al.   Autophagy

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

(2010) Paul A Marks   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+

(2009) Dante Rotili et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation

(2009) Yuval Samuni et al.   FREE RADICAL BIOLOGY AND MEDICINE

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS